FDA Drug Application (021567) for REYATAZ by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number021567
Product Number001
FormCAPSULE;ORAL
DosageEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameREYATAZ
Active IngredientATAZANAVIR SULFATE

Active IngredientCount
List of drugs with Active Ingredient ATAZANAVIR SULFATE6


Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB